Financials data is unavailable for this security.
View more
Year on year Ribomic Inc had revenues fall -100.00% from 65.97m to 0.00, though the company grew net income from a loss of 1.65bn to a smaller loss of 1.02bn.
| Gross margin | -- |
|---|---|
| Net profit margin | -45,053.58% |
| Operating margin | -51,591.46% |
| Return on assets | -25.76% |
|---|---|
| Return on equity | -26.68% |
| Return on investment | -26.68% |
More ▼
Cash flow in JPYView more
In 2024, cash reserves at Ribomic Inc fell by 725.44m. However, Cash Flow from Investing totalled 177.27m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 932.76m for operations while cash generated from financing totalled 27.65m.
| Cash flow per share | -25.50 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 80.86 |
|---|---|
| Tangible book value per share | 80.86 |
More ▼
Balance sheet in JPYView more
| Current ratio | 30.90 |
|---|---|
| Quick ratio | 30.87 |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
